Investor mix
3 investors on record; lead investors include Lilly Ventures, BioCrossroads.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developing anticancer heat shock protein (HSP) inhibitors
3 investors on record; lead investors include Lilly Ventures, BioCrossroads.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |